We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$213M
AUM Growth
+$57.3M
Cap. Flow
+$50.7M
Cap. Flow %
23.86%
Top 10 Hldgs %
19.94%
Holding
221
New
74
Increased
102
Reduced
37
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 11%
2 Financials 10.52%
3 Healthcare 8.26%
4 Industrials 6.13%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHA icon
176
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$238K 0.11%
+14,092
New +$241K
SNMP
177
DELISTED
Evolve Transition Infrastructure LP
SNMP
$238K 0.11%
716
+369
+106% +$125K
CMCSA icon
178
Comcast
CMCSA
$85B
$234K 0.11%
+5,930
New +$223K
SCHZ icon
179
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$233K 0.11%
+9,188
New +$240K
MRTX
180
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$232K 0.11%
12,550
+50
+0.4% +$776
GE icon
181
GE Aerospace
GE
$374B
$231K 0.11%
2,925
+1,096
+60% +$105K
RCL icon
182
Royal Caribbean
RCL
$85.1B
$228K 0.11%
1,913
+100
+6% +$12.4K
QQQE icon
183
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.33B
$227K 0.11%
+5,261
New +$223K
MMM icon
184
3M
MMM
$90.9B
$226K 0.11%
+1,155
New +$222K
GYRE icon
185
Gyre Therapeutics
GYRE
$641M
$222K 0.1%
+1,613
New +$82.3K
BKCC
186
DELISTED
BlackRock Capital Investment Corporation
BKCC
$217K 0.1%
+38,496
New +$265K
KO icon
187
Coca-Cola
KO
$377B
$215K 0.1%
+4,727
New +$217K
SDOG icon
188
ALPS Sector Dividend Dogs ETF
SDOG
$1.4B
$214K 0.1%
+4,768
New +$214K
PBJ icon
189
Invesco Food & Beverage ETF
PBJ
$108M
$213K 0.1%
+6,592
New +$216K
DE icon
190
Deere & Co
DE
$160B
$202K 0.1%
+1,278
New +$179K
NGNE icon
191
Neurogene
NGNE
$656M
$198K 0.09%
+793
New +$186K
MAV
192
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$186K 0.09%
+17,242
New +$198K
VKQ icon
193
Invesco Municipal Trust
VKQ
$541M
$175K 0.08%
+14,750
New +$184K
BCRX icon
194
BioCryst Pharmaceuticals
BCRX
$2.28B
$164K 0.08%
+33,500
New +$162K
SLV icon
195
iShares Silver Trust
SLV
$28B
$163K 0.08%
+10,221
New +$161K
FOLD
196
DELISTED
Amicus Therapeutics
FOLD
$154K 0.07%
+10,750
New +$148K
ARRY
197
DELISTED
Array Biopharma Inc
ARRY
$143K 0.07%
+11,177
New +$127K
SIRI icon
198
SiriusXM
SIRI
$9.98B
$121K 0.06%
2,272
+192
+9% +$10.6K
SN
199
DELISTED
Sanchez Energy Corporation
SN
$121K 0.06%
22,793
-5,872
-20% -$27.8K
UDF
200
DELISTED
UNITED DEV FDG IV COM SHS OF BENE INT (TX)
UDF
$111K 0.05%
+36,111
New +$111K

Similar funds

Kalos Management's Q4 2017 Portfolio in Review

As of Q4 2017, Kalos Management held 221 positions worth $213M, up 37% from $155M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Kalos Management deployed $50.7M of net new capital in Q4 2017, opening 74 new positions and adding to 102 existing holdings. Its largest new stake was Schwab US Broad Market ETF: 342,276 shares worth $3.65M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $2.83M trimmed.

  • Kalos Management's largest Q4 2017 buy was Schwab US Broad Market ETF: 342,276 shares worth $3.65M.
  • Kalos Management added most to FS KKR Capital in Q4 2017, an estimated $4.04M increase.
  • Kalos Management's biggest Q4 2017 reduction was Invesco QQQ Trust, cutting an estimated $2.83M.
  • Kalos Management fully exited Target in Q4 2017, selling an estimated $2.21M.
  • Kalos Management's ten largest holdings make up 20% of its $213M portfolio in Q4 2017.
  • Kalos Management opened 74 new positions and closed 8 in Q4 2017.
  • Kalos Management's portfolio value rose 37% quarter-over-quarter to $213M.

Based on Kalos Management's 13F filing for Q4 2017, filed 14 Feb 2018.